Ardelyx Inc
Change company Symbol lookup
Select an option...
ARDX Ardelyx Inc
APPH AppHarvest Inc
MACQW MCAP Acquisition Corp *W EXP 02/18/2026
QCOM Qualcomm Inc
NEXNF NEXE Innovations Inc
GRCL Gracell Biotechnologies Inc
NRG NRG Energy Inc
VNO Vornado Realty Trust
COTY Coty Inc
RPHM Reneo Pharmaceuticals Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Ardelyx, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of medicines to improve treatment for people with kidney and cardiorenal diseases. The Company's product pipeline includes Tenapanor, IBSRELA, RDX013 Program, and RDX020 Program. The Tenapanor is a medicine for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor for the control of serum phosphorus has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). RDX013 Program is a small molecule potassium secretagogue program for the potential treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis. It has a discovery program targeting the inhibition of intestinal bicarbonate exchange for the treatment of metabolic acidosis.

Closing Price
$1.31
Day's Change
-0.04 (-2.96%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.35
Day's Low
1.31
Volume
(Light)
Volume:
1,236,817

10-day average volume:
2,733,701
1,236,817
  • Prev Close
    1.35
  • Today's Open
    1.33
  • Day's Range
    1.31-1.35
  • Avg Vol (10-day)
    2.7M
  • Last (time)
    4:00p ET 09/24/21
  • Last (size)
    5
  • 52-Wk Range
    1.25 - 9.23
    LowHigh
  • (04/15/21 - 09/15/21)
    4.80%
  • 145.2%
  • Market Cap
    135.1M
  • Shares Outstanding
    103.1M
  • -1.31
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.9
  • 83.35
  • (% of float 09/15/21)
    7.75

Latest News

September 24, 2021
5:00 pm ET
Accesswire
3:46 pm ET
Newsfile
12:22 pm ET
Accesswire
11:00 am ET
Accesswire
11:00 am ET
BusinessWire
9:58 am ET
Globe Newswire
9:46 am ET
Newsfile
8:15 am ET
Accesswire
September 23, 2021
8:52 pm ET
Newsfile
7:20 pm ET
Globe Newswire
11:35 am ET
Accesswire
11:01 am ET
Accesswire
9:15 am ET
Accesswire
8:28 am ET
Accesswire
5:40 am ET
Accesswire
September 22, 2021
9:08 pm ET
Globe Newswire
6:36 pm ET
Accesswire
5:03 pm ET
PR Newswire
4:17 pm ET
BusinessWire
12:10 pm ET
Globe Newswire
8:02 am ET
Accesswire
September 21, 2021
3:41 pm ET
Accesswire
2:23 pm ET
Newsfile
9:00 am ET
Accesswire
8:20 am ET
Accesswire
September 20, 2021
7:15 pm ET
Accesswire
6:41 pm ET
Newsfile
10:40 am ET
Accesswire
10:07 am ET
Newsfile
9:20 am ET
Accesswire
8:30 am ET
Accesswire
September 19, 2021
10:23 am ET
Accesswire
September 18, 2021
10:02 am ET
Globe Newswire
September 17, 2021
7:15 pm ET
Globe Newswire
6:06 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.